Efficacy and safety of zhibitai in the treatment of hyperlipidemia: A systematic review and meta-analysis
Objective: To evaluate the efficacy and safety of Zhibitai (ZBT) in the treatment of patients with hyperlipidemia (HLP).Methods: A search of 8 electronic databases was conducted to find randomized controlled trials (RCTs), to evaluate the efficacy and safety of ZBT for the treatment of HLP. The risk...
Main Authors: | Chunyang Wang, Wentai Pang, Xuechen Du, Jiani Zhai, Mengyuan Zhong, Ming Zhuang, Jiali An, Lujia Cao, Li Zhang, Wenke Zheng, Junhua Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.974995/full |
Similar Items
-
Severe hyperlipidemia pancreatitis induced by taking tamoxifen after breast cancer surgery—Case report
by: Chao Zhai, et al.
Published: (2023-03-01) -
Integrated Transcriptomics and Metabolomics Reveal the Mechanism of Alliin in Improving Hyperlipidemia
by: Min Zhang, et al.
Published: (2023-09-01) -
Lifestyle Change Programs in the Management of Hyperlipidemia
by: Sevket Balta, et al.
Published: (2012-11-01) -
ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
by: Fu Zhong, et al.
Published: (2022-04-01) -
Effect of Corn Ferulic Acid on Lipid Metabolism and Liver Injury in Hyperlipidemia Rats
by: Naidan ZHANG, et al.
Published: (2023-08-01)